Drug Shortage Report for OMNIPAQUE 240

Last updated on 2022-05-20 History
Report ID 160525
Drug Identification Number 02172739
Brand name OMNIPAQUE 240
Common or Proper name iohexol injection USP
Company Name GE HEALTHCARE CANADA INC
Market Status MARKETED
Active Ingredient(s) IOHEXOL
Strength(s) 518MG
Dosage form(s) SOLUTION
Route of administration INTRAVASCULAR SUBARACHNOIDAL INTRAVASCULAR SUBARACHNOIDAL
Packaging size 50 mL
ATC code V08AB
ATC description X-RAY CONTRAST MEDIA, IODINATED
Reason for shortage Other (Please describe in comments)
Anticipated start date 2022-05-19
Actual start date
Estimated end date Unknown
Actual end date
Shortage status Actual shortage
Updated date 2022-05-20
Company comments Covid Related Shutdown in China. This is a fluid situation that we are working through daily. We will keep all customers informed on what orders to expect during this period so they can plan accordingly.
Health Canada comments
Tier 3 Status No
Contact Address 1919 MINNESOTA COURT
MISSISSAUGA, ONTARIO
CANADA L5N 0C9
Company contact information 800-387-7146 canadainfo@ge.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v6 2022-05-20 English Compare
v5 2022-05-17 French Compare
v4 2022-05-17 English Compare
v3 2022-05-14 English Compare
v2 2022-05-13 French Compare
v1 2022-05-13 English Compare

Showing 1 to 6 of 6